Skip to main content
. Author manuscript; available in PMC: 2020 Jun 15.
Published in final edited form as: Int J Gynecol Cancer. 2020 May 5;30(6):717–723. doi: 10.1136/ijgc-2020-001241

Figure 1.

Figure 1.

Patient selection for inclusion into study.

Patients included had FIGO grade 1 EEC, no myometrial invasion, and no lymphovascular space invasion. Synchronous ovarian malignancy was an exclusion criterion. Pelvic/peritoneal fluid cytology positive for carcinoma was not an exclusion criterion. EEC, endometrioid endometrial adenocarcinoma; MI, myometrial invasion; LVSI, lymphovascular space invasion.